Wealthspire Advisors (Maryland)’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History

Wealthspire Advisors (Maryland)’s Portfolio NBSE Stock Details NBSE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-25	Closed	-$1K	–	2224
2019 Q1	$1K	Hold	25	–	–	﹤0.01%	2420
2018 Q4	$1K	Hold	25	–	–	﹤0.01%	2362
2018 Q3	$2K	Hold	25	–	–	﹤0.01%	2216
2018 Q2	$2K	Hold	25	–	–	﹤0.01%	2222
2018 Q1	$2K	Buy	+25	New	+$3.72K	﹤0.01%	2237

Other funds holding NBSE

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

FNY Investment Advisers New York $277M AUM 98.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Mariner Investment Group Harrison, New York $330M AUM 25.25% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

Sandy Spring Bank Olney, Maryland $2.38B AUM 8.14% 1-Year Est. Return

Compagnie Lombard Odier SCmA 1204 Geneva, Switzerland $8.13B AUM 26.03% 1-Year Est. Return